SCHEMBL3670916

SCHEMBL3670916

CCOC(=O)CCCn1c(=O)n(C2CCN(C(=O)O)[C@@H](CCCN(Cc3ccccc3)Cc3ccccc3)C2)c2ccccc21.C[C@@H](CNC(=S)N1CCC(n2c(=O)[nH]c3ccccc32)CC1)N(Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHRM2 P08172 2/20 0.38
▸ CHRM1 P11229 2/20 0.38
▸ CHRM3 P20309 2/20 0.38
▸ CHRM4 P08173 1/20 0.38
▸ CHRM5 P08912 1/20 0.38
▸ ALDH1A1 P00352 2/20 0.36
▸ BCHE P06276 1/20 0.35
▸ ACHE P22303 1/20 0.35
▸ CACNA1G O43497 1/20 0.35
▸ CACNA1H O95180 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ PMP22 Q01453 1/20 0.34
▸ NPSR1 Q6W5P4 1/20 0.34
▸ PLD1 Q13393 5/20 0.34
▸ HSD11B1 P28845 2/20 0.34
▸ OPRM1 P35372 2/20 0.33
▸ OPRL1 P41146 1/20 0.33
▸ CALCRL Q16602 1/20 0.33
▸ CYP2D6 P10635 2/20 0.33
▸ MLNR O43193 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4804462 0.83 CACNA1G (0.43) ALDH1A1CACNA1GCACNA1HKDM4EOPRM1
SCHEMBL4799701 0.83 BCHE (0.36) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL4804471 0.79 CACNA1G (0.43) ALDH1A1CACNA1GCACNA1HKDM4EOPRM1
SCHEMBL4804476 0.79 CACNA1G (0.43) ALDH1A1CACNA1GCACNA1HKDM4EOPRM1
SCHEMBL4803178 0.78 KDM4E (0.43) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL4784349 0.78 CCR5 (0.40) ALDH1A1BCHEACHEKDM4EPMP22
SCHEMBL1832853 0.76 OPRM1 (0.52) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL1832858 0.76 OPRM1 (0.52) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL1837752 0.76 TNKS (0.51) CHRM2CHRM1CHRM3CHRM4CHRM5
SCHEMBL1835272 0.76 OPRM1 (0.50) CHRM2CHRM1CHRM3ALDH1A1BCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP claimed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO claimed
EP-2155676-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS Commissariat à l'Energie Atomique (FR) 2010-02-24 — — EP disclosed
WO-2008146172-A2 COMPOUNDS WITH ANTIPARASITIC ACTIVITY, APPLICATIONS THEREOF TO THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY APICOMPLEXANS COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-12-04 — — WO disclosed
Send feedback